122 related articles for article (PubMed ID: 21925261)
1. Immunomodulation by poly-YE reduces organophosphate-induced brain damage.
Finkelstein A; Kunis G; Berkutzki T; Ronen A; Krivoy A; Yoles E; Last D; Mardor Y; Van Shura K; McFarland E; Capacio BA; Eisner C; Gonzales M; Gregorowicz D; Eisenkraft A; McDonough JH; Schwartz M
Brain Behav Immun; 2012 Jan; 26(1):159-69. PubMed ID: 21925261
[TBL] [Abstract][Full Text] [Related]
2. Using MRI for the assessment of paraoxon-induced brain damage and efficacy of antidotal treatment.
Rosman Y; Eisenkraft A; Krivoy A; Schein O; Makarovski I; Shrot S; Ramaty E; Shilderman EB; Kapon J; Gilat E; Kadar T; Maier S; Daniels D; Shneor R; Salomon S; Tamar G; Last D; Mardor Y
J Appl Toxicol; 2012 Jun; 32(6):409-16. PubMed ID: 21861267
[TBL] [Abstract][Full Text] [Related]
3. Early brain magnetic resonance imaging can predict short and long-term outcomes after organophosphate poisoning in a rat model.
Shrot S; Tauber M; Shiyovich A; Milk N; Rosman Y; Eisenkraft A; Kadar T; Kassirer M; Cohen Y
Neurotoxicology; 2015 May; 48():206-16. PubMed ID: 25912464
[TBL] [Abstract][Full Text] [Related]
4. The organophosphate-induced acute-phase response is characterized by synthesis of alpha 1-acid glycoprotein that exhibits an immunomodulatory effect.
Ivanović-Matić S; Poznanović G; Grigorov I; Dinić S; Mihailović M; Grdović N; Uskoković A; Martinović V; Arambasić J; Petrović M; Bogojević D
J Appl Toxicol; 2008 Jan; 28(1):63-71. PubMed ID: 17497759
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of novel small peptides in vitro and after brain injury.
Faden AI; Movsesyan VA; Knoblach SM; Ahmed F; Cernak I
Neuropharmacology; 2005 Sep; 49(3):410-24. PubMed ID: 15907950
[TBL] [Abstract][Full Text] [Related]
6. Acute neuropathology in soman poisoned rats.
McLeod CG; Singer AW; Harrington DG
Neurotoxicology; 1984; 5(2):53-7. PubMed ID: 6542190
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging reveals that galantamine prevents structural brain damage induced by an acute exposure of guinea pigs to soman.
Gullapalli RP; Aracava Y; Zhuo J; Helal Neto E; Wang J; Makris G; Merchenthaler I; Pereira EF; Albuquerque EX
Neurotoxicology; 2010 Jan; 31(1):67-76. PubMed ID: 19782102
[TBL] [Abstract][Full Text] [Related]
8. N-acetyl-aspartyl-glutamate and inhibition of glutamate carboxypeptidases protects against soman-induced neuropathology.
Guo H; Liu J; Van Shura K; Chen H; Flora MN; Myers TM; McDonough JH; McCabe JT
Neurotoxicology; 2015 May; 48():180-91. PubMed ID: 25825357
[TBL] [Abstract][Full Text] [Related]
9. Analyzing large data sets acquired through telemetry from rats exposed to organophosphorous compounds: an EEG study.
de Araujo Furtado M; Zheng A; Sedigh-Sarvestani M; Lumley L; Lichtenstein S; Yourick D
J Neurosci Methods; 2009 Oct; 184(1):176-83. PubMed ID: 19632275
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic changes in the brain, heart, and skeletal muscle of rhesus macaques, ten days after exposure to soman (an organophosphorus nerve agent).
Britt JO; Martin JL; Okerberg CV; Dick EJ
Comp Med; 2000 Apr; 50(2):133-9. PubMed ID: 10857003
[TBL] [Abstract][Full Text] [Related]
11. Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain.
Chapman S; Kadar T; Gilat E
Neurotoxicology; 2006 Mar; 27(2):277-83. PubMed ID: 16406030
[TBL] [Abstract][Full Text] [Related]
12. Single whole-body exposure to sarin vapor in rats: long-term neuronal and behavioral deficits.
Grauer E; Chapman S; Rabinovitz I; Raveh L; Weissman BA; Kadar T; Allon N
Toxicol Appl Pharmacol; 2008 Mar; 227(2):265-74. PubMed ID: 18164360
[TBL] [Abstract][Full Text] [Related]
13. Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman.
Lallement G; Baubichon D; Clarençon D; Galonnier M; Peoc'h M; Carpentier P
Neurotoxicology; 1999 Aug; 20(4):675-84. PubMed ID: 10499365
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection from soman-induced seizures in the rodent: evaluation with diffusion- and T2-weighted magnetic resonance imaging.
Bhagat YA; Obenaus A; Hamilton MG; Mikler J; Kendall EJ
Neurotoxicology; 2005 Dec; 26(6):1001-13. PubMed ID: 15982742
[TBL] [Abstract][Full Text] [Related]
15. Nerve agent intoxication: recent neuropathophysiological findings and subsequent impact on medical management prospects.
Collombet JM
Toxicol Appl Pharmacol; 2011 Sep; 255(3):229-41. PubMed ID: 21791221
[TBL] [Abstract][Full Text] [Related]
16. Putative role of proteolysis and inflammatory response in the toxicity of nerve and blister chemical warfare agents: implications for multi-threat medical countermeasures.
Cowan FM; Broomfield CA; Lenz DE; Smith WJ
J Appl Toxicol; 2003; 23(3):177-86. PubMed ID: 12794939
[TBL] [Abstract][Full Text] [Related]
17. GK 11: promising additional neuroprotective therapy for organophosphate poisoning.
Lallement G; Mestries JC; Privat A; Brochier G; Baubichon D; Carpentier P; Kamenka JM; Sentenac-Roumanou H; Burckhart MF; Peoc'h M
Neurotoxicology; 1997; 18(3):851-6. PubMed ID: 9339831
[TBL] [Abstract][Full Text] [Related]
18. Alpha-linolenic acid is a potent neuroprotective agent against soman-induced neuropathology.
Pan H; Hu XZ; Jacobowitz DM; Chen C; McDonough J; Van Shura K; Lyman M; Marini AM
Neurotoxicology; 2012 Oct; 33(5):1219-29. PubMed ID: 22884490
[TBL] [Abstract][Full Text] [Related]
19. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
[TBL] [Abstract][Full Text] [Related]
20. The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning.
Raveh L; Chapman S; Cohen G; Alkalay D; Gilat E; Rabinovitz I; Weissman BA
Neurotoxicology; 1999 Aug; 20(4):551-9. PubMed ID: 10499354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
